Dr. Ricaurte is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4940 Eastern Avenue
Baltimore, MD 21224Phone+1 410-550-5624Fax+1 410-550-7694
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1984 - 1987
- McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 1983 - 1984
- Northwestern University The Feinberg School of MedicineClass of 1981
Certifications & Licensure
- MD State Medical License 1988 - 2025
- FL State Medical License 2015 - 2017
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Publications & Presentations
PubMed
- 201 citations3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humansThomas D. Steele, Una D. McCann, George A. Ricaurte
Addiction. 1994-05-01 - 454 citationsPositron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beingsUna D. McCann, Zsolt Szabo, Ursula Scheffel, Robert F. Dannals, George A. Ricaurte
Lancet. 1998-10-31 - 95 citationsEffect of Temperature on Dopamine Transporter Function and Intracellular Accumulation of Methamphetamine: Implications for Methamphetamine-Induced Dopaminergic Neuroto...Tao Xie, Una D. McCann, Saejeong Kim, Jie Yuan, George A. Ricaurte
The Journal of Neuroscience. 2000-10-15
Grant Support
- PET Studies Of Amphetamine Treatment Of ADHDNational Institute Of Mental Health2009–2012
- Studies Of Substituted Amphetamine NeurotoxicityNational Institute On Drug Abuse2005–2009
- ADHD Treatment &Amphetamine NeurotoxicityEunice Kennedy Shriver National Institute Of Child Health &Human Development2005–2007
- MDMA Neurotoxicity In Humans: Occurrence And ConsequencesNational Center For Research Resources2004–2007
- PET Studies Of Methamphtamine Neurotoxicity In HumansNational Center For Research Resources2004–2006
- PET Studies Of Humans Exposed To MDMA (ECSTASY)National Center For Research Resources2004–2006
- Methamphetamine Neurotoxicity In Nonhuman PrimatesNational Institute On Drug Abuse2002–2006
- MDMA Neurotoxicity In Humans: Occurence &ConsequencesNational Institute On Drug Abuse2002–2006
- MDMA Neurotoxicity In Nonhuman PrimatesNational Institute On Drug Abuse2002–2005
- Substituted Amphetamine NeurotoxicityNational Institute On Drug Abuse1999–2003
- Gene Expression And Methamphetamine NeurotoxicityNational Institute On Drug Abuse2000–2002
- Safety Assessment Of Fenfluramine &Phentermine In HumansNational Center For Research Resources1999–2002
- PET &Csf Studies Of Humans Exposed To MDMA (ECSTASY)National Center For Research Resources1999–2002
- MDMA Neurotoxicity In Humans-- Occurence &ConsequenceNational Center For Research Resources1997–2002
- Safety Assessment Of Fenfluramine/PhentermineNational Institute On Drug Abuse1997–2001
- PET Studies Of Methamphetamine Neurotoxicity On HumansNational Center For Research Resources2000
- PET &Csf Studies Of Humans Exposed To MDMANational Center For Research Resources2000
- Assessment Of Fenfluramine &Phentermine In HumansNational Center For Research Resources2000
- PET Studies Of Methamphetamine Neurotoxicity In HumansNational Institute On Drug Abuse1998–2000
- PET And CSF Studies Of Humans Exposed To MethylenedioxymethamphetamineNational Center For Research Resources1998–1999
- MDMA Neurotoxicity--Occurrence &ConsequencesNational Institute On Drug Abuse1996–1999
- NDMA Neurotoxicity--Permanent Or TransientNational Institute On Drug Abuse1995–1999
- MDMA Neurotoxicity: Preclinical And Clinical EvaluationNational Institute On Drug Abuse1996–1998
- PET And CSF Studies Of Humans Exposed To MethamphetamineNational Center For Research Resources1996–1997
- PET Imaging Serotonin Neurotoxicity With (11c)Mcn5652National Institute On Drug Abuse1995–1997
- PET Imaging DA Neurotoxicity With 11C Win-35,428National Institute On Drug Abuse1995–1996
- NDMA Neurotoxicity--Occurrence &ConsequencesNational Institute On Drug Abuse1995
- CNational Institute On Drug Abuse1994–1995
- PET Imaging DA Neurotoxicity With ?11c? Win-35,428National Institute On Drug Abuse1994
- MDMA Neurotoxicity In Humans--Occurrence And ConsequencesNational Center For Research Resources1993–1994
- N-Methylated Analogues Of MDMA &FenfluramineNational Institute On Drug Abuse1991–1993
- MDMA Neurotoxicity In Primate: Permanent Or Transient?National Institute On Drug Abuse1989–1993
- MDMA Neurotoxicity In Humans--Occurrance &ConsequencesNational Institute On Drug Abuse1989–1991
- NDMA Neurotoxicity In Humans--Occurrence And ConsequencesNational Center For Research Resources1990
Other Languages
- Spanish
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/george-ricaurte
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: